GlobalData now forecasts the Pharma data and analytics market to reach $2.1 billion by 2028, making real data essential for healthcare research. In particular, it is important to link different data sets to provide new insights that can drive improvements in patient care.
However, the linking process has its challenges. In addition to siloed data and the “Frankenstein” database, researchers should be careful to adhere to regulatory guidelines such as HIPAA when linking data successfully.
Leveraging the expertise of the real-world data reader MarketScan®, Truven Company, the new podcast explains how researchers can make the most of their data links. Guenter Sauter PhD, Sr. Liisa Palmer PhD, Director of Technology Product Management at Marketscan and portfolio leader of Marketscan's Real World Data Research & Analytics, highlights common pitfalls and proven solutions.
“A very important aspect for us when linking data is compliance,” explains Sauter. “At the same time, what's very important to us is not only to maintain the usefulness of the data and identify data almost arbitrarily to achieve compliance, but also to consider the specific use cases that our clients have in mind.”
The podcast also considers how to effectively use linked data.
“At the end of the day, the linked data itself does not provide value,” says Palmer. “It's linked, the work won't finish. Value comes from being able to link in a proper, robust, and compliant way, but on the other side there is a team of interdisciplinary researchers who understand how to generate research that provides value.”
Listen to today's podcasts for free and get the latest insights:
A podcast produced by GlobalData and sponsored by MarketScan.
